Stability indicating RP-LC determination of sildenafil citrate (Viagra) in pure form and in pharmaceutical samples
- 22 May 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 29 (4) , 743-748
- https://doi.org/10.1016/s0731-7085(02)00123-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLCJournal of Pharmaceutical and Biomedical Analysis, 2001
- FIA of sildenafil citrate using UV-detectionJournal of Pharmaceutical and Biomedical Analysis, 2001
- REVERSED-PHASE HPLC DETERMINATION OF SILDENAFIL CITRATE IN THE PRESENCE OF ITS OXIDATIVE-INDUCED DEGRADATION PRODUCTSJournal of Liquid Chromatography & Related Technologies, 2000
- Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related CompoundsMolecular Pharmacology, 1999
- SILDENAFIL, A TYPE-5 CGMP PHOSPHODIESTERASE INHIBITOR, SPECIFICALLY AMPLIFIES ENDOGENOUS cGMP-DEPENDENT RELAXATION IN RABBIT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITROJournal of Urology, 1998
- Development of an assay for the simultaneous determination of sildenfail (viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997